Juvederm Filler

JUVEDERM ULTRA XC

Juvederm Ultra XC is a dermal filler that uses hyaluronic acid, a protein compound found naturally in the body. Juvederm Ultra XC provides volume to the treated area and helps with reducing the appearance of fine lines. The Juvederm includes 0.3% lidocaine to minimize any discomfort  during treatment. Dr. Day’s expertise leaves patients extremely satisfied with the fuller, yet natural look that Juvederm can provide!

 

JUVEDERM ULTRA XC vs. JUVEDERM ULTRA PLUS XC

Juvederm Ultra XC vs Juvederm Ultra Plus XC, what is the difference? Both compounds are able to provide volume and reduce the appearance of fine lines and wrinkles. Juvederm Ultra Plus XC includes a more dense form of hyaluronic acid substance and is also the most cross-linked version of the product. With the increased amount of cross-linkages, Juvederm Ultra Plus XC has a greater volumizing effect, especially around the cheeks, lips, and very deep nasolabial folds. Schedule an appointment today to see which filler Dr. Day recommends for you!

 

JUVEDERM VOLUMA
 Juvederm Voluma is an excellent choice for patients who wish to address volume loss, especially in their cheeks. Juvederm Voluma is able to help lift and contour, while also addressing volume loss! Juvederm Voluma is formulated with a numbing agent, lidocaine, so that patients will experience minimal discomfort during the injection process. Juvederm Voluma is a hyaluronic acid gel filler, and is thicker and more firm than other types of fillers. Additionally, the patented Vycross technology helps to prevent degradation of the product after injection. These two distinctions allow for the filler to last up to two years! Juvederm Voluma provides patients with a youthful profile and smoother contour.

 

JUVEDERM VOLLURE
Juvederm Vollure is an aesthetic dermal filler that uses hyaluronic acid as well as Vycross technology. The Vycross technology includes combining high and low molecular weight to create a better cross-linking of the hyaluronic chains in the substance. With Dr. Day’s exceptional skill, she is able to improve the look of lines and wrinkles, especially the “parentheses” lines around the nose and mouth.

 

JUVEDERM VOLBELLA

 Juvederm Volbella includes hyaluronic acid with Vycross technology to provide patients with a lasting effect. Juvederm Volbella is frequently used to increase the volume in the lips and perioral region. Volbella can be used to enhance the size and shape of lips as well as provide a smoother and more symmetrical appearance. Juvederm Volbella can enhance a patient’s natural look and leave them looking youthful and beautiful.

 

 

Estrogen Study

This study is being done to see whether applying a cream with estradiol (a form of estrogen) to the face can improve overall skin quality and help reduce fine lines and wrinkles in peri- and post-menopausal women, and how this relates to epigenetic changes in the skin. A part of the study will also include applying an extra rapamycin analog cream to the face, which is also believed to improve overall skin quality and help reduce fine lines and wrinkles.

WHY THIS MATTERS

Skin aging in peri- and post-menopausal women is deeply tied to hormonal shifts. This study explores whether topical estradiol can turn back the clock – cellularly.

Eligibility

You MAY qualify if you can answer YES to all:

I am a healthy female (peri or menopausal) between the ages of 40 and 65.

I have not had any cosmetic facial treatments in the last 1-3 months.

I have not had any GLP-1 treatments in the last 6 months.

Study Design and Duration

The study includes daily evening application of study cream for 12 weeks, followed by 4 weeks with no test product use. In total, the study will last 16 weeks or approximately 4 months.

Apply to the Estrogen Study

Topical Scalp Serum Containing RLX‑201 in Subjects With Mild‑to‑Moderate Hair Thinning 

Purpose of the Study 

The purpose of this study is to evaluate the safety, tolerability, and effectiveness of a scalp serum containing RLX‑201 when applied once daily for 20 weeks in men and women with mild‑to‑moderate hair thinning. The study will assess changes in hair density, hair thickness, and overall scalp health using clinical evaluations, imaging tools, and participant self‑assessments. 

Eligibility

You MAY qualify if you can answer YES to all:

I am a healthy male or female between the ages of 30 and 60.

Self‑perceived mild‑to‑moderate hair thinning.

I have NOT used minoxidil, light therapy, or other hair growth treatments within 3 months.

I have NOT used medications affecting hair growth (e.g., finasteride, spironolactone, cyproterone acetate, 5‑alpha‑reductase inhibitors) or a GLP-1 within 6 months.

Study Design and Duration 

This is a single‑center clinical study lasting approximately 20 weeks. If you agree to participate, you will be asked to attend study visits at the following time points: Baseline, and Weeks 2, 4, 8, 12, 16, and 20. 

Apply Here